Ke-Qin Hu at UC Irvine

Ke-Qin Hu Professor of Clinical Medicine School of Medicine Director, Hepatology Services, H.H. Chao Comprehensive Digestive Disease Center School of Medicine M.S., Tongji Medical University, 1985, Infectious Diseases and Immunology M.D., Tongji Medical University, 1982 Phone: [phone] Fax: [phone] Email: [e-mail] University of California, Irvine 101 The City Dr S Bldg 56 Orange, CA 92868

Research Interests	Natural history and new treatments of viral hepatitis B and C; natural history and chemoprevention of primary liver cancer
Academic Distinctions	Research Support Award, Loma Linda University School of Medicine
Research Abstract	Dr. Ke-Qin Hu is the Director of Hepatology Services and Associate Professor of Clinical Medicine at UCI School of Medicine. Dr. Hu received his medical education and training in Tongji Medical University, China. He become Board Certified in Internal Medicine in US after his residency at Huntington Memorial Hospital, Pasadena, and completed a fellowship in Hepatology at the USC Liver Unit. Dr. Hu has a long-standing research interest in both basic and clinical research of viral hepatitis B and C, and primary liver cancer. Dr. Hu’s current clinical research focuses on understanding how hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is associated with fatty infiltrates in the liver and disease progression, and how viral hepatitis B and C are associated with liver cancer. As an active clinical investigator, Dr. Hu participates in several important clinical trials that tests new treatments for hepatitis B and C. Currently, his laboratory focuses on searching new chemoprevention of liver cancer. Dr. Hu has co-authored more than 100 research papers, book chapters, and review articles, including publications in Proc. Natl. Acad. Sci. USA, Journal of Clinical Investigation, and Hepatology. Dr. Hu serves as an associate editor for several medical journals.